TLRY Tilray Brands, Inc.

bearish · high conviction track record → $5.65 +0.10 (+1.8%)
Mkt Cap $639M 52wk $3.50 - $23.20 18d ago
Factor divergence: DIVERGENCE: estimate_revisions, analyst_revisions bullish vs price_momentum bearish
Est. revisions: +8.0% (1 up, 0 down in 30d)
Factor Model (net +1.4)

Factor Model

net +1.4 3.2 / 10
Est. Revisions
+0.5
Insider Activity
+0.0
Momentum
-0.7
Analyst Rev.
+1.0
Narrative Gap
+0.0

Tilray's Short Interest Rises 35% to 16.4%

Watch: Monitor the late June rescheduling hearing and Q2 earnings for signs that regulatory changes ease margins and shift sentiment.

Short interest on Tilray shares surged 35% to 16.4% of the float, reaching 19.4M shares short with 2.8 days to cover. This rise amplifies bearish pressure amid a 30.6% price drop from its 52-week high and weakening volume. Insider selling and a downtrend with -21% monthly return confirm negative market sentiment despite a recent high-conviction bullish view on potential cannabis deregulation.

The jump in short interest signals rising skepticism and downside risk for Tilray shares, potentially pressuring price further in a volatile, bear-dominated market.

Evidence

Fundamentals & Data ▾
Tilray Brands, Inc. Healthcare · Drug Manufacturers - Specialty & Generic
Mkt Cap
$639M
Beta
1.94
52w Range
$3.50 - $23.20
Short Interest
19.4M 16.36%
Days to Cover
2.8 +36%
Technicals downtrend
vs 20d MA
-0.8%
from 52w Hi
-29.5%
Vol (20d)
41%
1w return
+6.5%
1m return
-19.4%
Vol ratio
0.7x
Insiders
selling 0B / 1S
EPS Estimate
$0.27 +8.0% 30d 1up / 0dn
Est. Dispersion
0% 1 analysts
Analyst Target
$10 $6 - $24
Options P/C
0.11
Financials
Revenue
$207M +11% YoY
FCF
$-26M
Gross Margin
27%
Op Margin
-10%
Momentum: decelerating
Top Holders
Citadel $27M
Track Record (1/1 correct) ▾

Direction History

1/1 correct at 5 days
2026-05-14 bearish -0.7%
15 signals · latest 18d ago

Keep reading the market

Direction shifts, insider clusters, filing red flags, and earnings call changes stay published on the site.